Morgan Stanley Aquestive Therapeutics, Inc. Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Morgan Stanley holds 1,527,289 shares of AQST stock, worth $3.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,527,289

Previous 736,889 107.26%

Holding current value

$3.63 Million

Previous $2.61 Million 69.82%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.54 - $3.75 $2.01 Million - $2.96 Million	790,400 Added 107.26%	1,527,289 $4.43 Million
Q4 2024 Feb 14, 2025	BUY	$3.46 - $5.64 $226,284 - $368,856	65,400 Added 9.74%	736,889 $2.61 Million
Q3 2024 May 14, 2025	BUY	$2.4 - $5.09 $277,207 - $587,910	115,503 Added 20.77%	671,489 $3.34 Million
Q3 2024 Nov 14, 2024	BUY	$2.4 - $5.09 $277,207 - $587,910	115,503 Added 20.77%	671,489 $3.34 Million
Q2 2024 May 14, 2025	SELL	$2.31 - $4.5 $417,885 - $814,063	-180,903 Reduced 24.55%	555,986 $1.45 Million
Q2 2024 Oct 17, 2024	BUY	$2.31 - $4.5 $1.07 Million - $2.08 Million	463,064 Added 498.34%	555,986 $1.45 Million
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.5 $1.07 Million - $2.08 Million	463,064 Added 498.34%	555,986 $1.45 Million
Q1 2024 Oct 17, 2024	SELL	$2.01 - $6.09 $930,758 - $2.82 Million	-463,064 Reduced 83.29%	92,922 $395,000
Q1 2024 Aug 16, 2024	BUY	$2.01 - $6.09 $138,201 - $418,730	68,757 Added 284.53%	92,922 $395,000
Q1 2024 May 15, 2024	BUY	$2.01 - $6.09 $138,201 - $418,730	68,757 Added 284.53%	92,922 $395,000
Q4 2023 Aug 16, 2024	SELL	$1.29 - $2.47 $686,049 - $1.31 Million	-531,821 Reduced 95.65%	24,165 $48,000
Q4 2023 Feb 13, 2024	BUY	$1.29 - $2.47 $10,614 - $20,323	8,228 Added 51.63%	24,165 $48,000
Q3 2023 Nov 15, 2023	SELL	$1.5 - $2.24 $8,898 - $13,287	-5,932 Reduced 27.13%	15,937 $24,000
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.49 $18,230 - $42,825	17,199 Added 368.29%	21,869 $36,000
Q1 2023 May 15, 2023	SELL	$0.72 - $1.15 $721 - $1,152	-1,002 Reduced 17.67%	4,670 $5,000
Q4 2022 Feb 14, 2023	SELL	$0.77 - $1.18 $21,335 - $32,696	-27,709 Reduced 83.01%	5,672 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.63 - $1.73 $8,515 - $23,384	13,517 Added 68.05%	33,381 $39,000
Q2 2022 Oct 27, 2022	SELL	$0.64 - $2.57 $48,812 - $196,011	-76,269 Reduced 79.34%	19,864 $13,000
Q2 2022 Aug 15, 2022	SELL	$0.64 - $2.57 $48,812 - $196,011	-76,269 Reduced 79.34%	19,864 $13,000
Q1 2022 Oct 27, 2022	BUY	$2.28 - $4.26 $173,893 - $324,905	76,269 Added 383.96%	96,133 $250,000
Q1 2022 May 13, 2022	SELL	$2.28 - $4.26 $226,606 - $423,397	-99,389 Reduced 50.83%	96,133 $250,000
Q4 2021 Feb 14, 2022	SELL	$3.69 - $6.37 $186,809 - $322,487	-50,626 Reduced 20.57%	195,522 $760,000
Q3 2021 Nov 15, 2021	BUY	$3.25 - $4.66 $799,981 - $1.15 Million	246,148 New	246,148 $1.07 Million

Others Institutions Holding AQST

# of Institutions

129

Shares Held

44.5M

Call Options Held

44.6K

Put Options Held

182K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $127M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account